Healthcare equipment appears undervalued, while life science tools show weak quality. iShares Global Healthcare ETF provides global healthcare exposure but has underperformed the U.S.-focused XLV both long and short term with a higher expense ratio. 10 stocks cheaper than their peers in June.
While the broad market is overpriced, value still exists in the healthcare sector, especially in healthcare providers and healthcare equipment. iShares Global Healthcare ETF offers global healthcare exposure with slightly better fundamentals and lower company-specific risk than XLV. 10 stocks cheaper than their peers in February.
After a late-2025 rebound eased policy fears, healthcare ETFs like IXJ are gaining attention as investors position for a sector comeback in 2026.
| LSE Exchange | US Country |
The description provided outlines a fund that primarily focuses on investing in the healthcare sector, adhering to a strategy that ensures at least 80% of its assets are committed to securities forming part of its underlying index. These securities are selected based on their economic characteristics, closely mirroring those of the index components and aiming to reflect the performance of companies considered pivotal within the healthcare industry by the index provider. Furthermore, the fund is open to diversifying its investment approach by allocating up to 20% of its assets towards futures, options, swap contracts, and maintaining liquidity through cash and cash equivalents. This strategy indicates a versatile yet sector-focused approach hoping to capitalize on the healthcare sector's growth and importance in the global market.
This forms the core of the fund's investment strategy, allocating at least 80% of its assets towards securities that are part of its underlying index. These investments are chosen for their potential to replicate the economic characteristics and performance of key players within the healthcare sector.
Beyond direct index components, the fund seeks out investments that, while not components themselves, offer substantially identical economic characteristics. This approach ensures diversification and alignment with the fund's healthcare sector focus, optimizing potential for growth and returns.
As part of its strategy to manage risk and enhance potential returns, up to 20% of the fund's assets may be allocated to futures, options, and swap contracts. These financial instruments allow for strategic positioning in the market, providing opportunities for hedging and profit under various market conditions.
Investing in cash and cash equivalents enables the fund to maintain liquidity, ensuring enough flexibility to make timely investments and respond to market opportunities or necessities. This component of the fund's strategy highlights its commitment to maintaining a balance between investing in growth opportunities and managing liquidity needs.